TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

Volver

Resultados 127 resultados LastUpdate Última actualización 22/07/2017 [15:07:00] pdf PDF




Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 6 nextPage   Mostrar por página


SYSTEM AND METHOD FOR INSULIN PUMP MEDICAL DEVICE INCLUDING A SLIDER ASSEMBLY WHEREIN IMAGES ON DISPLAY ALLOW FOR HIGHLIGHTING AND MAGNIFYING IMAGES

NºPublicación: US2017197027A1 13/07/2017

Solicitante:
DEKA PRODUCTS LP [US]

Resumen de: US2017197027A1

A medical system includes an input assembly for receiving one or more user inputs. The input assembly includes at least one slider assembly for providing an input signal. Processing logic receives the input signal from the input assembly and provides a first output signal and a second output signal. A display assembly is configured to receive, at least in part, the first output signal from the processing logic and render information viewable by the user. The second output signal is provided to one or more medical system components. The information rendered on the display assembly may be manipulatable by the user and at least a portion of the information rendered may be magnified.



traducir


 

SYSTEMS AND METHODS FOR DETERMINING A CONCENTRATIONOF GLUCOSE IN EXHALED BREADTH

NºPublicación: US2017196481A1 13/07/2017

Solicitante:
PURDUE RESEARCH FOUNDATION [US]

Resumen de: US2017196481A1

The invention generally relates to systems and methods for determining a concentration of glucose in exhaled breadth. In certain aspects, the invention provides a system including a sample collection module configured to collect a condensate sample produced from a mixture of exhaled breadth from a subject and ambient air. The condensate sample includes exhaled breadth glucose and ambient air glucose. The system also includes an assay module configured to assay the condensate sample for total glucose. The system also includes an analysis module that includes a processor that is configured to determine a total glucose concentration in the condensate sample, and adjust the total glucose concentration based upon a concentration of the ambient air glucose in the condensate sample, thereby determining a concentration of the exhaled breadth glucose in the exhaled breadth from the subject.



traducir


 

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2017196491A1 13/07/2017

Solicitante:
DEXCOM INC [US]

Resumen de: US2017196491A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.



traducir


 

PREDICTIVE INSTRUMENT TO IDENTIFY PATIENTS FOR USE OF PHARMACOLOGICAL CARDIAC METABOLIC SUPPORT

NºPublicación: US2017196505A1 13/07/2017

Solicitante:
TUFTS MEDICAL CENTER INC [US]

Resumen de: US2017196505A1

A purpose-made predictive instrument for the administration of cardiac metabolic support for acute coronary syndromes (ACS, which include unstable angina and acute myocardial infarction) that particularly identifies those most likely to benefit from treatment. In some examples, such a predictive instrument is used for real-time decision support for the administration of treatments such as glucoseinsulin-potassium (GIK).



traducir


 

APPLICATION OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN SENSOR SYSTEMS, DEVICES, AND RELATED METHODS

NºPublicación: US2017197030A1 13/07/2017

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: US2017197030A1

A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.



traducir


 

FLUID DELIVERY SYSTEM

NºPublicación: WO2017118536A1 13/07/2017

Solicitante:
VICENTRA B V [NL]

Resumen de: WO2017118536A1

A fluid delivery system (1) includes a reservoir (7) for storing a fluid, a pumping chamber (8) and an actuator (20). The pumping chamber (8) has a volume, an inlet valve (48) providing selective fluid communication between the pumping chamber volume and the reservoir, an outlet valve (49), and a membrane (47) the displacement of which changes the pumping chamber volume. The actuator (20) moves a drive member (21) in reciprocating motion. The actuator (20) is disposed in a housing (9) having an aperture (36) from which the drive member projects. The reservoir (7) and the pumping chamber (8) are arranged in a cartridge (3) removably attachable to the housing. When the cartridge (3) is attached to the housing (9) the drive member (20) is operatively coupled to the pumping chamber membrane (47). The fluid delivery system may be applied to an infusion system for the infusion of a liquid therapeutic product, such as insulin.



traducir


 

USER INTERFACE FOR DIABETES MANAGEMENT SYSTEM

NºPublicación: US2017199985A1 13/07/2017

Solicitante:
BIGFOOT BIOMEDICAL INC [US]

Resumen de: US2017199985A1

A diabetes management system including a pump for dispensing a medicant and a control device for controlling the pump includes a user interface for controlling functions of the pump and providing information related to operation of the pump and other information. The user interface can display blood glucose information and insulin dosing data such that a user can appropriately act on the information and/or gain confidence that the diabetes management system is operating appropriately to manage the disease. User interfaces provided herein can include displays of current and projected glucose values, bolus calculators, charts displaying glucose levels and/or insulin delivery data, system maintenance reminders, system status information, patient configuration input screens, and log-in screens. Diabetes management systems can include insulin pumps, continuous glucose monitors, blood glucose monitors, mobile computing devices, servers, and/or other insulin delivery devices (e.g., insulin pens).



traducir


 

METHOD FOR RECOMMENDING, TO USER WITH DIABETES SYMPTOMS, FOOD PERSONALIZED WITH CONSIDERATION FOR AMOUNT OF EXERCISE

NºPublicación: WO2017116003A1 06/07/2017

Solicitante:
I-SENS INC [KR]

Resumen de: WO2017116003A1

The present invention relates to a method for providing, to a user with diabetes symptoms, information on recommended food or food that should be avoided, and provides a food recommending method capable of: determining, on the basis of a user's food consumption amount, food type, blood sugar level, and amount of exercise, information on recommended food, or food that should be avoided, which is personalized to the user, so as to provide the same to the user; and providing information on recommended food, or food which should be avoided, which is personalized to the user, even from a menu comprising a plurality of foods.



traducir


 

METHODS, SYSTEMS, AND DEVICES FOR SENSOR FUSION

NºPublicación: WO2017116504A1 06/07/2017

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: WO2017116504A1

A single, optimal, fused sensor glucose value may be calculated based on respective sensor glucose values of a plurality of redundant working electrodes (WEs) of a glucose sensor. Respective electrochemical impedance spectroscopy (EIS) procedures may be performed for each of the WEs to obtain values of membrane resistance (Rmem) for each WE. A noise value and a calibration factor (CF) value may be calculated for each WE, and respective fusion weights may be calculated for Rmem, noise, and CF for each WE. An overall fusion weight may then be calculated based on the WE' s Rmem fusion weight, noise fusion weight, and CF fusion weight, such that a single, optimal, fused sensor glucose value may be calculated based on the respective overall fusion weight and sensor glucose value of each of the plurality of redundant working electrodes.



traducir


 

METHODS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: WO2017116503A1 06/07/2017

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: WO2017116503A1

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms. Calibration of a glucose sensor may also be performed using a calibration factor based on the age of the sensor. Finally, a calibration interval for a glucose sensor may be determined.



traducir


 

RETROSPECTIVE SENSOR CALIBRATION METHODS

NºPublicación: WO2017116505A1 06/07/2017

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: WO2017116505A1

A method for retrospective calibration of a glucose sensor uses stored values of measured working electrode current (Isig) to calculate a final sensor glucose (SG) value retrospectively. The Isig values may be preprocessed, discrete wavelet decomposition applied. At least one machine learning model, such as, e.g., Genetic Programing (GP) and Regression Decision Tree (DT), may be used to calculate SG values based on the Isig values and the discrete wavelet decomposition. Other inputs may include, e.g., counter electrode voltage (Vcntr) and Electrochemical Impedance Spectroscopy (EIS) data. A plurality of machine learning models may be used to generate respective SG values, which are then fused to generate a fused SG. Fused SG values may be filtered to smooth the data, and blanked if necessary.



traducir


 

A CONTACT LENS DESIGN SENSING TEAR GLUCOSE LEVEL

NºPublicación: WO2017116350A1 06/07/2017

Solicitante:
DOKUZ EYLUL UNIV REKTORLUGU [TR]

Resumen de: WO2017116350A1

The invention is intended for patients with diabetes, and relates to a type of contact lens by means of which tear glucose level is monitored thanks to a biosensor disposed thereon.



traducir


 

METHOD AND SYSTEM FOR NON-INVASIVE OPTICAL BLOOD GLUCOSE DETECTION UTILIZING SPECTRAL DATA ANALYSIS

NºPublicación: US2017188917A1 06/07/2017

Solicitante:
ST LOUIS MEDICAL DEVICES INC [US]

Resumen de: US2017188917A1

Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes at least one light source configured to strike a target area of a sample, at least one light detector positioned to receive light from the at least one light source and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, a processor configured to receive the output signal from the at least one light detector based on the received output signal, calculate the attenuance attributable to blood in a sample present in the target area with a ratio factor, eliminate effect of uncertainty caused by temperature dependent detector response of the at least one light detector, and then determine a blood glucose level associated with a sample present in the target area based on the calculated attenuance with the processor.



traducir


 

Server apparatus and wearable device for blood glucose monitoring and associated methods

NºPublicación: AU2015350582A1 06/07/2017

Solicitante:
NANYANG TECH UNIV

Resumen de: AU2015350582A1

A server apparatus (102) for monitoring blood glucose in a wearer (106) of a wearable device (104) is configured to perform the first mode of operation of blood glucose monitoring for the wearer of the device using data obtained by a radio- frequency blood glucose monitoring module (124) in the wearable device. The server apparatus is also configured to perform a second mode of operation of blood glucose monitoring using data obtained by a light spectroscopy blood glucose monitoring module (126) in the wearable device. The server apparatus performs a threshold comparison between a reference blood glucose value for the wearer of the device and the threshold glucose value (314). A first one of the first mode of operation and the second mode of operation is selected in dependence of the threshold comparison.



traducir


 

GLUCAGON ADMINISTRATION SYSTEM AND METHODS

NºPublicación: US2017189615A1 06/07/2017

Solicitante:
BIGFOOT BIOMEDICAL INC [US]

Resumen de: US2017189615A1

Some embodiments a glucagon administration system can provide a suggested glucagon dosage based on one or more particular parameters (e.g., the user's recent blood glucose characteristics, a glucagon sensitivity value of the user, and other parameters). In some circumstances, the glucagon administration system can receive information indicative of the user's blood glucose level and suggest a glucagon dosage that is at least partially dependent upon a previously stored glucagon sensitivity for the user.



traducir


 

COMPOSITION AND METHOD FOR MANAGEMENT OF DIABETES OR PRE-DIABETES

NºPublicación: US2017189332A1 06/07/2017

Solicitante:
OMNIBLEND INNOVATION PTY LTD [AU]

Resumen de: WO2013173874A2

A drink for moderating blood glucose levels produced by a meal in a human subject suffering diabetes or impaired glucose tolerance (IGT) the drink comprising:. at least one water soluble or water dispersible compound selected from the group consisting of amino acids, peptides and proteins in a total amount of at least 8g on a dry weight basis per serving of drink;. aqueous liquid in an amount of from 70ml to 400ml (preferably in an amount of from 100 ml to 250 ml and more preferably from 125 ml to 175 ml) per serving, and wherein the drink exhibits shear banding when subject to the shear banding test herein described.



traducir


 

Device to Collect Raman Photons for Non-Invasive Glucose Detector

NºPublicación: US2017188899A1 06/07/2017

Solicitante:
NI XUAN ZHONG [US]

Resumen de: US2017188899A1

The present invention relates to a device which uses optical fibers to form a tube hat for a finger tip to collect all Raman photons.



traducir


 

BIOINTERFACE LAYER FOR ANALYTE SENSORS

NºPublicación: US2017188922A1 06/07/2017

Solicitante:
DEXCOM INC [US]

Resumen de: US2017188922A1

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The biointerface layer increases sensor longevity and decrease sensor inaccuracy by inhibiting accumulation of cells, proteins, and other biological species on the outermost layers of the sensor.



traducir


 

ENZYME IMMOBILIZED ADHESIVE LAYER FOR ANALYTE SENSORS

NºPublicación: US2017188921A1 06/07/2017

Solicitante:
DEXCOM INC [US]

Resumen de: US2017188921A1

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.



traducir


 

DIFFUSION RESISTANCE LAYER FOR ANALYTE SENSORS

NºPublicación: WO2017117469A1 06/07/2017

Solicitante:
DEXCOM INC [US]

Resumen de: WO2017117469A1

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.



traducir


 

MEMBRANE LAYERS FOR ANALYTE SENSORS

NºPublicación: US2017188916A1 06/07/2017

Solicitante:
DEXCOM INC [US]

Resumen de: US2017188916A1

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise a diffusion-resistance layer, which can comprise a base polymer having a lowest Tg of greater than −50 C.



traducir


 

SYSTEMS AND METHODS FOR MULTIPLE ANALYTE ANALYSIS

NºPublicación: US2017191958A1 06/07/2017

Solicitante:
ROCHE DIABETES CARE INC [US]

Resumen de: US2017191958A1

Systems and methods for multiple analyte analysis are provided. In one embodiment, a method includes determining concentrations of first and second analytes in a sample. The first and second analytes may be, for example, glucose and hydroxybutyrate. In this form, an indication related to the measured concentration of hydroxybutyrate is provided in response to determining that the concentration of hydroxybutyrate is above a predetermined value. In a further aspect of this form, a quantitative indication representative of the measured glucose concentration is automatically provided regardless of the value of the measured glucose concentration. In another embodiment, a system includes a meter configured to interact with a test element to assess first and second analytes in a sample. Further embodiments, forms, objects, features, advantages, aspects, and benefits shall become apparent from the description and drawings.



traducir


 

System for Optimizing a Drug Dosage Regimen Over Time

NºPublicación: US2017189616A1 06/07/2017

Solicitante:
NOVO NORDISK AS [DK]

Resumen de: US2017189616A1

A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.



traducir


 

Inventive diabetic systems, tools, kits, and supplies for better diabetic living and mobility

NºPublicación: US2017189604A1 06/07/2017

Solicitante:
LEONARD LARRY [US]

Resumen de: US2017189604A1

A pocket sized diabetic kit carrying supplies that a diabetic patient will need for 24 hours includes but not limited to Lancet pen, lancets, small test strip bottle filled with test strips, blood test meter, one or more insulin types stored in a plurality of pre-filled syringes, one syringe splint or just one hard plunger, a plurality of alcohol pads, one blood plotter pad, Velcro straps and a syringe clipper. The pocket diabetic kit is compact, small and thin and can fit into a pocket so that a diabetic patient can be easily carried in the pants' pocket or other pockets without causing inconvenience or uncomfortable. The present invention also discloses ways to modify supplies including tools, medication syringes, etc.



traducir


 

DEVICES AND METHODS FOR ENHANCED SKIN PERFORATION FOR CONTINUOUS GLUCOSE MONITORING

Nº publicación: US2017188898A1 06/07/2017

Solicitante:
ARKAL INC [US]

Resumen de: US2017188898A1

The efficacy of tissue piercing elements in the area of transdermal drug delivery is well-documented. Multiple studies have shown that enhancement of skin permeation via creation of microscopic pores in the stratum corneum can greatly improve the delivery rates of drugs. However, skin perforation with tissue piercing elements is not the only factor affecting the rate of drug transport. Other factors including such as the formulation of the drug and rate of closure of the micropores closure also need to be considered. Similarly micro tissue piercing elements have been used with less success by several workers for continuous glucose monitoring.


traducir



 

Página1 de 6 nextPage Mostrar por página

Volver